Home | UCSF Helen Diller Family Comprehensive Cancer Center

International Breast Cancer Conference Features UCSF Experts

Annual Symposium Highlights State-of-the-Art Research and Treatment of Breast Cancer.

Thirdhand Smoke: This Hidden Danger Puts Kids and Adults at Risk

UCSF researcher and leading advocate Neal Benowitz, MD, explains the threat of lingering tobacco residue and how a new California law could help.

Seven Research Projects Funded through Cancer Health Outcomes SPORE

Seven investigators have been awarded grants this fall for research on factors driving differences in health outcomes in meningioma, prostate cancer, and breast cancer.

American Society of Hematology (ASH) 2025 Annual Meeting

UCSF Health Experts Spotlight Advances, Receive Recognition at National Hematology/Oncology Conference

Hematologists and oncologists from UCSF will share research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology – the American Society of Hematology’s (ASH) 67th Annual Meeting and Exposition. This year’s meeting will be held in Orlando, Dec. 6-9.

Improving Management and Treatment of Thyroid Cancer

UCSF’s Julie Ann Sosa, MD, co-led international task force establishing new clinical guidelines for the management of differentiated thyroid cancer.

From Undruggable to Unstoppable: A New Cancer Cure Target Emerges

NIH-funded discoveries by UCSF's Kevan Shokat, PhD have produced the world’s first drugs that target mutations in the KRAS gene which cause a quarter of all cancerous tumors.

SFMOMA - Art for Recovery exhibit viewed on opening night

Showcasing Art that Celebrates Creativity and Healing Amid Cancer

First of its kind display at SFMOMA by UCSF Health patients

UCSF Faculty and Fellows Present at 2025 AORTIC Conference

Our Global Cancer Program joined international collaborators at the African Organisation for Research and Training in Cancer (AORTIC) conference in Tunisia.

Lee May UCSF Multiple Myeloma patient standing next to a fence by an open field

‘Every Time I Relapsed, There Would Be a New Course of Therapy’

He was told cancer would kill him in two to four years. Fourteen years later, he credits a series of medications and treatments funded by the National Institutes of Health.

How AI is Changing Brain Tumor Surgery

High-tech imaging approaches allow neurosurgeons to interpret tissue samples during surgery to remove previously invisible malignant cells.

Gift Launches $200M Initiative for the Weill Cancer Hub West

Matching grant from Weill family creates collaborative research hub, uniting scientists from UCSF and Stanford Medicine to transform cancer care within a decade.